You'll see psoriasis patients on a new biotech drug, Raptiva.

December 2003

You'll see psoriasis patients on a new biotech drug, Raptiva. It's an antibody that blocks T-cells responsible for psoriasis.

Raptiva (efalizumab) is similar to Amevive (alefacept)... but each drug blocks different cell receptors.

Raptiva is for moderate to severe plaque psoriasis.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote